{"title": "New drug combination shows promise for common pediatric brain tumor", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/pharmaceuticals.xml", "value": "New drug combination shows promise for common pediatric brain tumor"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2019/03/190321200605.htm"}], "link": "https://www.sciencedaily.com/releases/2019/03/190321200605.htm", "summary": "A new combination treatment aimed at resistant and recurrent low-grade gliomas slowed tumor growth and killed tumor cells in laboratory and mouse models.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/pharmaceuticals.xml", "value": "A new combination treatment aimed at resistant and recurrent low-grade gliomas slowed tumor growth and killed tumor cells in laboratory and mouse models."}, "media_thumbnail": [{"url": "https://www.sciencedaily.com/images/2019/03/190321200605-large.jpg", "height": "171", "width": "300"}], "href": "", "published": "Thu, 21 Mar 2019 20:06:05 EDT", "published_parsed": [2019, 3, 22, 0, 6, 5, 4, 81, 0], "id": "https://www.sciencedaily.com/releases/2019/03/190321200605.htm", "guidislink": false}